简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-09-19 11:08 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma
2016-09-19 10:54 Glyxambi® (empagliflozin/linagliptin) approval recommended by CHMP for adults with type 2 diabetes in the European Union
2016-09-14 17:18 New LCP Monofilament Allows for MRI Guided Vascular Intervention
2016-09-13 10:32 Takeda Supports Global Expansion of the American Cancer Society’s Relay For Life (RFL)
2016-09-13 10:11 Samsung Bioepis' SB4 (BRENZYS™) Becomes First Etanercept Biosimilar to Receive Regulatory Approval in Canada
2016-09-12 09:57 Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease
2016-09-09 16:23 Wake Up! One in Three Meeting Attendees are Falling Asleep
2016-09-09 14:28 Patient Safety Movement Foundation & Global Sepsis Alliance Join Forces to Reduce Preventable Deaths from Sepsis
2016-09-09 13:56 Ausupreme International Holdings Limited Announced Subscription Results for Hong Kong Public Offering
2016-09-08 14:48 New analysis showed dose adjustment of Giotrif® (afatinib) improved tolerability without an apparent impact on efficacy in patients with EGFR mutation-positive non-small cell lung cancer
2016-09-08 13:56 GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance
2016-09-08 10:10 New long-term data demonstrates continued safety and beneficial effect of OFEV® (nintedanib) for patients with IPF
2016-09-08 09:59 Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine Candidate (TAK-003)
2016-09-07 10:08 Tiotropium Respimat® improved lung function in children with asthma aged 6-17 and is well-tolerated compared to placebo in children aged 1-171-5
2016-09-07 10:02 Philip Morris International Releases First “Update” on Their Scientific Research to Develop and Assess Potentially Reduced-Risk Products
2016-09-06 10:09 Simple blood test combined with exacerbation history may help to identify when to add ICS to COPD treatment
2016-09-06 09:51 New Data: Spiolto® Respimat® significantly improves exercise capacity in people with COPD
2016-09-05 12:29 Panasonic to Showcase Future Lifestyles at IFA 2016
2016-09-02 12:15 ReSound® Returns to the World’s Largest Consumer Electronics Show in Berlin to Showcase the Most Advanced Hearing Solutions
2016-09-02 10:14 Takeda to develop Zika Vaccine with up to $312 million in funding from US Government

Business Wire Weibo

Press Releases

Latest Releases